Saltar al contenido
Saltar al contenido

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 11 septiembre 2019. Database contains 222 unique substances/entries.
Filter the list
Latest update:
Date of intention:
Date of RMOA conclusion:

 
-
-
Austria
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
23/09/2014
Details
911-815-4
-
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
-
-
Austria
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
203-585-2
108-46-3
Finland
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/09/2019
Details
-
-
Sweden
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
02/02/2017
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140°C to 220°C (284°F to 428°F).
265-191-7
64742-88-7
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Pending
On hold
No suggestion yet
23/09/2014
Details
A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148.8°C to 204.4°C (300°F to 400°F).
232-489-3
8052-41-3
Denmark
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Pending
On hold
No suggestion yet
23/09/2014
Details
202-851-5
100-42-5
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/11/2014
Details
231-639-5
7664-93-9
Belgium
Carcinogenic
Exposure
Mutagenic
Under development
Under development
No suggestion yet
23/09/2014
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details
262-967-7
61788-32-7
Finland
Aggregated tonnage
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/09/2019
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Restriction
17/01/2019
Details
204-126-9
116-14-3
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/12/2018
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
452-830-1
-
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/01/2015
Details
203-625-9
108-88-3
Denmark
Mutagenic
Toxic for reproduction
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
203-625-9
108-88-3
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
201-071-2
77-94-1
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
22/01/2019
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/11/2016
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
215-157-2
1308-06-1
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
206-203-2
307-55-1
Germany
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
234-829-6
12035-72-2
Hungary
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/05/2017
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
237-158-7
13674-84-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
204-118-5
115-96-8
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
213-934-0
1067-53-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
13/06/2016
Details
701-028-2
-
France
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Other
24/05/2019
Details
237-159-2
13674-87-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
225-768-6
5064-31-3
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
206-196-6
307-24-4
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
05/01/2018
Details
259-048-8
54261-67-5
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
02/02/2017
Details
234-277-6
11059-65-7
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/07/2019
Details
205-288-3
137-30-4
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
202-853-6
100-44-7
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details

Export search results to:

Categories Display


Route: .live2